Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1375116 | Bioorganic & Medicinal Chemistry Letters | 2010 | 4 Pages |
Abstract
The identification and hit-to-lead exploration of a novel, potent and selective series of histamine H4 receptor inverse agonists is described. The initial hit, 3A (IC50 19 nM) was identified by means of a ligand-based virtual screening approach. Subsequent medicinal chemistry exploration yielded 18I which possessed increased potency (R-enantiomer IC50 1 nM) as well as enhanced microsomal stability.
Graphical abstractThe hit-to-lead exploration of a series of novel, potent and selective series of histamine H4 receptor inverse agonists originating from a virtual screening approach is described.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Sue Cramp, Hazel J. Dyke, Christopher Higgs, David E. Clark, Matthew Gill, Pascal Savy, Neil Jennings, Steve Price, Peter M. Lockey, Dennis Norman, Soraya Porres, Francis Wilson, Alison Jones, Nigel Ramsden, Raffaella Mangano, Dan Leggate,